CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing breakthrough aims to fix immune cells in rare disease
Disease control Recruiting nowThis early-stage trial tests a new gene-editing approach for X-linked chronic granulomatous disease (CGD), a rare immune disorder. Researchers will take stem cells from 10 adult males, fix a specific genetic mutation using base editing, and return the corrected cells after mild c…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
NIH launches major study to unlock secrets of rare immune diseases
Knowledge-focused Recruiting nowThis study aims to learn more about immune system problems that cause frequent infections or inflammation. Researchers will observe up to 3,500 patients, their family members, and healthy volunteers over one year. The goal is to track how these diseases progress and find genetic …
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
New study looks at immune system clues in rare disease
Knowledge-focused Recruiting nowThis study is for people with chronic granulomatous disease (CGD), a rare immune disorder. Researchers will measure levels of antibodies against adenovirus and markers of inflammation in the blood. The goal is to better understand the immune system in CGD. About 60 adults and chi…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated May 15, 2026 12:06 UTC